Literature DB >> 3018543

Activation of immediate-early, early, and late promoters by temperature-sensitive and wild-type forms of herpes simplex virus type 1 protein ICP4.

N A DeLuca, P A Schaffer.   

Abstract

To better define the activities on herpes simplex virus type 1 gene expression of temperature-sensitive and wild-type forms of the transcriptional regulatory protein ICP4, regulatory sequences from immediate-early, early, and late herpes simplex virus genes were fused to the gene for chloramphenicol acetyltransferase (CAT). These constructs were used in trans induction and cotransfection experiments with wild-type and temperature-sensitive mutant alleles of ICP4. The ICP4 genes used in this study were cloned from the KOS strain (wild type) and two phenotypically distinct temperature-sensitive ICP4 mutants, tsB32 and tsL14 (DeLuca et al., J. Virol. 52:767-776, 1984), both alone and in conjunction with three other immediate-early genes. The latter series of plasmids was used to assess the influence of additional immediate-early gene products on gene expression in the presence of a given ICP4 allele. The results of this study demonstrate that the phenotypes of these ICP4 mutants observed in cell culture at the nonpermissive temperature were determined in part by activities associated with the mutant ICP4 polypeptides and that these activities differed from those of wild-type ICP4. Low levels of wild-type ICP4 had a marginal but reproducible stimulatory effect on immediate-early CAT gene expression, especially the pIE4/5CAT chimera. This effect was diminished with increasing quantities of ICP4, suggesting an inhibitory role for the wild-type form of the protein. The ICP4 mutants had a strong stimulatory effect on immediate-early CAT expression, consistent with their phenotypes at 39 degrees C. The mutant forms of the ICP4 polypeptide differed in their ability to induce CAT activity from an early chimeric gene. Thus, the tsL14 form of ICP4 was effective in early gene induction (i.e., ptkCAT was induced), whereas the ICP4 derived from tsB32 was slightly inhibitory. Cotransfection of tsB32 ICP4 simultaneously with other immediate-early genes resulted in a marginal increase in ptkCAT induction. This induction was enhanced when the gene for ICP4 was inactivated by restriction enzyme cleavage, substantiating the inhibitory effect of the tsB32 form of ICP4. The two mutant ICP4 genes (tsB32 and tsL14) were unable to trans-activate either of the late CAT constructs (p5CAT and pL42CAT) tested. Cotransfecting tsL14 ICP4 with the other immediate-early genes resulted in activation of p5CAT but not pL42CAT. Taken together, these studies demonstrate that (i) low levels of wild-type ICP4 have stimulatory effect on immediate-early promoters and that higher concentrations of wild-type ICP4 have an inhibitory effect on these promoters, (ii) isolated mutant form of ICP4 exhibit activities that reflect the phenotypes of the mutants from which they were isolated, and (iii) immediate-early gene products other than ICP4 are involved in determining the distinct phenotypes of the two mutants at 39 degrees Celsius.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3018543      PMCID: PMC366918          DOI: 10.1128/mcb.5.8.1997-2008.1985

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  42 in total

1.  Orientation of herpes simplex virus type 1 immediate early mRNA's.

Authors:  J B Clements; J McLauchlan; D J McGeoch
Journal:  Nucleic Acids Res       Date:  1979-09-11       Impact factor: 16.971

2.  Cooperation between herpes simplex virus specific alpha protein and host cell RNA polymerase II in the transcription of viral deoxypyrimidine kinase.

Authors:  W C Leung
Journal:  Can J Microbiol       Date:  1980-03       Impact factor: 2.419

3.  Fine-structure mapping and functional analysis of temperature-sensitive mutants in the gene encoding the herpes simplex virus type 1 immediate early protein VP175.

Authors:  R A Dixon; P A Schaffer
Journal:  J Virol       Date:  1980-10       Impact factor: 5.103

4.  Transcriptional control signals of a eukaryotic protein-coding gene.

Authors:  S L McKnight; R Kingsbury
Journal:  Science       Date:  1982-07-23       Impact factor: 47.728

5.  Viral DNA synthesis is required for the efficient expression of specific herpes simplex virus type 1 mRNA species.

Authors:  L E Holland; K P Anderson; C Shipman; E K Wagner
Journal:  Virology       Date:  1980-02       Impact factor: 3.616

6.  Abnormal properties of an immediate early polypeptide in cells infected with the herpes simplex virus type 1 mutant tsK.

Authors:  C M Preston
Journal:  J Virol       Date:  1979-11       Impact factor: 5.103

7.  Herpes simplex virus phosphoproteins. I. Phosphate cycles on and off some viral polypeptides and can alter their affinity for DNA.

Authors:  K W Wilcox; A Kohn; E Sklyanskaya; B Roizman
Journal:  J Virol       Date:  1980-01       Impact factor: 5.103

8.  Fine-structure mapping of herpes simplex virus type 1 temperature-sensitive mutations within the short repeat region of the genome.

Authors:  V G Preston
Journal:  J Virol       Date:  1981-07       Impact factor: 5.103

9.  Cloning of herpes simplex virus type 1 sequences representing the whole genome.

Authors:  A L Goldin; R M Sandri-Goldin; M Levine; J C Glorioso
Journal:  J Virol       Date:  1981-04       Impact factor: 5.103

10.  Regulation of alpha genes of herpes simplex virus: expression of chimeric genes produced by fusion of thymidine kinase with alpha gene promoters.

Authors:  L E Post; S Mackem; B Roizman
Journal:  Cell       Date:  1981-05       Impact factor: 41.582

View more
  172 in total

1.  The initiator element in a herpes simplex virus type 1 late-gene promoter enhances activation by ICP4, resulting in abundant late-gene expression.

Authors:  Dool-Bboon Kim; Susan Zabierowski; Neal A DeLuca
Journal:  J Virol       Date:  2002-02       Impact factor: 5.103

2.  Origin binding protein-containing protein-DNA complex formation at herpes simplex virus type 1 oriS: role in oriS-dependent DNA replication.

Authors:  J A Isler; P A Schaffer
Journal:  J Virol       Date:  2001-08       Impact factor: 5.103

3.  Temperature-dependent conformational changes in herpes simplex virus ICP4 that affect transcription activation.

Authors:  Peter Compel; Neal A DeLuca
Journal:  J Virol       Date:  2003-03       Impact factor: 5.103

4.  Mapping the termini and intron of the spliced immediate-early transcript of equine herpesvirus 1.

Authors:  R N Harty; C F Colle; F J Grundy; D J O'Callaghan
Journal:  J Virol       Date:  1989-12       Impact factor: 5.103

5.  The regions important for the activator and repressor functions of herpes simplex virus type 1 alpha protein ICP27 map to the C-terminal half of the molecule.

Authors:  M A Hardwicke; P J Vaughan; R E Sekulovich; R O'Conner; R M Sandri-Goldin
Journal:  J Virol       Date:  1989-11       Impact factor: 5.103

Review 6.  HSV-1-based vectors for gene therapy of neurological diseases and brain tumors: part I. HSV-1 structure, replication and pathogenesis.

Authors:  A Jacobs; X O Breakefield; C Fraefel
Journal:  Neoplasia       Date:  1999-11       Impact factor: 5.715

7.  Transactivation of latent Marek's disease herpesvirus genes in QT35, a quail fibroblast cell line, by herpesvirus of turkeys.

Authors:  T Yamaguchi; S L Kaplan; P Wakenell; K A Schat
Journal:  J Virol       Date:  2000-11       Impact factor: 5.103

8.  Herpes simplex virus type 1 ICP4 promotes transcription preinitiation complex formation by enhancing the binding of TFIID to DNA.

Authors:  B Grondin; N DeLuca
Journal:  J Virol       Date:  2000-12       Impact factor: 5.103

9.  Herpes simplex virus type 1 ICP0 plays a critical role in the de novo synthesis of infectious virus following transfection of viral DNA.

Authors:  W Z Cai; P A Schaffer
Journal:  J Virol       Date:  1989-11       Impact factor: 5.103

10.  Visualization of parental HSV-1 genomes and replication compartments in association with ND10 in live infected cells.

Authors:  George Sourvinos; Roger D Everett
Journal:  EMBO J       Date:  2002-09-16       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.